DK362889A - Thiazolderivater - Google Patents

Thiazolderivater Download PDF

Info

Publication number
DK362889A
DK362889A DK362889A DK362889A DK362889A DK 362889 A DK362889 A DK 362889A DK 362889 A DK362889 A DK 362889A DK 362889 A DK362889 A DK 362889A DK 362889 A DK362889 A DK 362889A
Authority
DK
Denmark
Prior art keywords
substituted
group
hydrogen atom
acyl group
thiazole
Prior art date
Application number
DK362889A
Other languages
English (en)
Other versions
DK362889D0 (da
Inventor
Tetsuya Aono
Masahiro Suno
Go Kito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK362889D0 publication Critical patent/DK362889D0/da
Publication of DK362889A publication Critical patent/DK362889A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK362889A 1988-07-22 1989-07-21 Thiazolderivater DK362889A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18422088 1988-07-22
JP8653689 1989-04-05

Publications (2)

Publication Number Publication Date
DK362889D0 DK362889D0 (da) 1989-07-21
DK362889A true DK362889A (da) 1990-01-23

Family

ID=26427638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK362889A DK362889A (da) 1988-07-22 1989-07-21 Thiazolderivater

Country Status (11)

Country Link
US (3) US4956360A (da)
EP (1) EP0351856B1 (da)
JP (1) JP3054738B2 (da)
KR (1) KR970011396B1 (da)
AT (1) ATE184610T1 (da)
AU (1) AU610739B2 (da)
CA (1) CA1336431C (da)
DE (1) DE68929074T2 (da)
DK (1) DK362889A (da)
IL (1) IL91063A (da)
NZ (1) NZ230042A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89351A0 (en) * 1988-03-14 1989-09-10 Lundbeck & Co As H 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL97249A (en) * 1990-02-23 1995-01-24 Takeda Chemical Industries Ltd Compounds of 7,6,5,4-tetrahydrothiazole] B-5,4 [pyridine and compounds of 5,6-dihydro-H4-pyrrolo] D-3,2 [thiazole, their manufacture, and pharmaceutical compositions including or
GB9219779D0 (en) * 1992-09-18 1992-10-28 Rhone Poulenc Agriculture Compositions of new matter
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0743064A1 (en) * 1995-05-17 1996-11-20 Eli Lilly And Company Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6433935B2 (en) 1996-07-02 2002-08-13 Three-Five Systems, Inc. Display illumination system
AU5886500A (en) * 1999-06-23 2001-01-09 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
US6649318B1 (en) 2000-04-20 2003-11-18 Eastman Kodak Company Self-contained imaging media comprising microencapsulated color formers and a resilient layer
EP1424101A3 (en) * 2002-11-29 2004-08-18 NOZAKI, Masako Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis
US7148248B2 (en) 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
CA2547651C (en) * 2003-12-01 2015-06-23 Cambridge University Technical Services Limited Anti-inflammatory agents
CA2612217A1 (en) 2005-06-15 2006-12-21 Cambridge Enterprise Limited Anti-inflammatory agents
GB201009603D0 (en) * 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG17968A3 (da) * 1970-08-14 1974-03-05
JPS53121781A (en) * 1977-03-30 1978-10-24 Torii Yakuhin Kk Caprolactum derivatives
AU554388B2 (en) * 1981-06-15 1986-08-21 American Home Products Corporation Alpha-phenyl-2-(aza)benzothiazolylthioglycolic acid derivatives
JPS5837097A (ja) * 1981-08-28 1983-03-04 味の素株式会社 界面活性剤
JPS63283591A (ja) * 1986-12-17 1988-11-21 Toray Ind Inc L−α−アミノ−ε−カプロラクタムの製造法

Also Published As

Publication number Publication date
EP0351856A3 (en) 1991-08-07
DK362889D0 (da) 1989-07-21
DE68929074D1 (de) 1999-10-21
EP0351856B1 (en) 1999-09-15
EP0351856A2 (en) 1990-01-24
KR970011396B1 (ko) 1997-07-10
US5300639A (en) 1994-04-05
JP3054738B2 (ja) 2000-06-19
JPH0347188A (ja) 1991-02-28
IL91063A0 (en) 1990-02-09
IL91063A (en) 1994-12-29
US4956360A (en) 1990-09-11
AU610739B2 (en) 1991-05-23
NZ230042A (en) 1990-10-26
CA1336431C (en) 1995-07-25
DE68929074T2 (de) 2000-01-05
KR910002873A (ko) 1991-02-26
US5118806A (en) 1992-06-02
ATE184610T1 (de) 1999-10-15
AU3886289A (en) 1990-01-25

Similar Documents

Publication Publication Date Title
DK362889A (da) Thiazolderivater
NO904377L (no) Tricykliske karbapenemforbindelser.
DE68908724D1 (de) Imidoaromatische Percarbonsäure.
AU2867889A (en) Imide-aromatic peroxyacids as bleaching agents
FI982436A0 (fi) Kondensoituneet heterosykliset yhdisteet
ES2075850T3 (es) Derivados de beta-lactama.
HK1003000A1 (en) Spiro compounds
ATE87921T1 (de) Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen.
TW198022B (da)
HK1000126A1 (en) Process for preparing 1,5-benzothiazepine derivatives
DE3884499D1 (de) Heterozyklische peroxycarbonsaeure.
IT1219690B (it) Perossiacidi eterociclici azotati monopersolfati
DE69317920D1 (de) Thiazolderivate von Alcoxyacrylaten mit fungizider Wirkung

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment